AUVELITY
NDC 81968-045, dextromethorphan hydrobromide, bupropion hydrochloride, tablet, multilayer, extended release, from Axsome Therapeutics, Inc..
- Product NDC
- 81968-045
- Status
- Listed
- Labeler
- Axsome Therapeutics, Inc.
- Dosage form
- TABLET, MULTILAYER, EXTENDED RELEASE
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- NDA
- Application
- NDA215430
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/81968-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- DEXTROMETHORPHAN HYDROBROMIDE45 mg/1
- BUPROPION HYDROCHLORIDE105 mg/1
Pharmacologic classes
Aminoketone [EPC]; Dopamine Uptake Inhibitors [MoA]; Increased Dopamine Activity [PE]; Increased Norepinephrine Activity [PE]; Norepinephrine Uptake Inhibitors [MoA]; Sigma-1 Agonist [EPC]; Sigma-1 Receptor Agonists [MoA]; Uncompetitive N-methyl-D-aspartate Receptor Antagonist [EPC]; Uncompetitive NMDA Receptor Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 81968-045-14 | 81968004514 | 1 BOTTLE in 1 CARTON (81968-045-14) / 14 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE |
| 81968-045-30 | 81968004530 | 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-30) |
| 81968-045-31 | 81968004531 | 1 BOTTLE in 1 CARTON (81968-045-31) / 30 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE |
| 81968-045-60 | 81968004560 | 60 TABLET, MULTILAYER, EXTENDED RELEASE in 1 BOTTLE (81968-045-60) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/dcefda7c-9a68-278e-e053-2995a90aec79NADAC price for package 81968004530
GET /v1/drugs/nadac/81968004530NADAC price for package 81968004560
GET /v1/drugs/nadac/81968004560
Use it
Look up 81968-045 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/81968-045 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 81968-045. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.